Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
methotrexat ebewe innrennslisþykkni, lausn 100 mg/ml
ebewe pharma ges.m.b.h.nfg. kg - methotrexatum inn - innrennslisþykkni, lausn - 100 mg/ml
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
metoject stungulyf, lausn í áfylltri sprautu 50 mg/ml
medac gesellschaft für klinische spezialpräparate gmbh - methotrexatum inn - stungulyf, lausn í áfylltri sprautu - 50 mg/ml
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
metojectpen (metoject) stungulyf, lausn í áfylltum lyfjapenna 10 mg
medac gesellschaft für klinische spezialpräparate gmbh - methotrexatum inn - stungulyf, lausn í áfylltum lyfjapenna - 10 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
metojectpen (metoject) stungulyf, lausn í áfylltum lyfjapenna 12,5 mg
medac gesellschaft für klinische spezialpräparate gmbh - methotrexatum inn - stungulyf, lausn í áfylltum lyfjapenna - 12,5 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
metojectpen (metoject) stungulyf, lausn í áfylltum lyfjapenna 15 mg
medac gesellschaft für klinische spezialpräparate gmbh - methotrexatum inn - stungulyf, lausn í áfylltum lyfjapenna - 15 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
metojectpen (metoject) stungulyf, lausn í áfylltum lyfjapenna 22,5 mg
medac gesellschaft für klinische spezialpräparate gmbh - methotrexatum inn - stungulyf, lausn í áfylltum lyfjapenna - 22,5 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
methotrexate orion pharma (methotrexate orion) tafla 2,5 mg
orion corporation - methotrexatum inn - tafla - 2,5 mg
Evrópusambandið -
íslenska -
EMA (European Medicines Agency)
nordimet
nordic group b.v. - stendur - arthritis, psoriatic; psoriasis; arthritis, juvenile rheumatoid; arthritis, rheumatoid - Æxlishemjandi lyf - nordimet is indicated for the treatment of:active rheumatoid arthritis in adult patients,polyarthritic forms of severe, active juvenile idiopathic arthritis (jia), when the response to nonsteroidal anti-inflammatory drugs (nsaids) has been inadequate,moderate to severe plaque psoriasis in adults who are candidates for systemic therapy, and severe psoriatic arthritis in adult patients, induction of remission in moderate steroid-dependent crohn's disease in adult patients, in combination with corticosteroids and for maintenance of remission, as monotherapy, in patients who have responded to methotrexate.
Evrópusambandið -
íslenska -
EMA (European Medicines Agency)
pedea
recordati rare diseases - Íbúprófen - slagæðarásar, einkaleyfi - hjarta meðferð - meðferð á blóðfrumumyndandi einkaleyfalyfjum í nýburum yngri en 34 vikna meðgöngutíma.
Evrópusambandið -
íslenska -
EMA (European Medicines Agency)
thiotepa riemser
esteve pharmaceuticals gmbh - thiotepa - hematopoietic stem cell transplantation; neoplasms - Æxlishemjandi lyf - thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients. thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.